tiprankstipranks
Trending News
More News >
Immunotech Biopharm Ltd (HK:6978)
:6978
Hong Kong Market

Immunotech Biopharm Ltd (6978) Income Statement

Compare
1 Followers

Immunotech Biopharm Ltd Income Statement

Last quarter (Q4 2024), Immunotech Biopharm Ltd's total revenue was ¥0.00, a decrease of ― from the same quarter last year. In Q4, Immunotech Biopharm Ltd's net income was ¥-94.40M. See Immunotech Biopharm Ltd’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 0.00¥ 0.00¥ 0.00¥ 0.00¥ 0.00
Gross Profit
¥ 0.00¥ 0.00¥ 0.00¥ 0.00¥ 0.00
Operating Expenses
¥ 198.78M¥ 230.55M¥ 268.83M¥ 335.59M¥ 383.23M
Depreciation and Amortization
¥ 52.22M¥ 52.22M¥ 44.07M¥ 21.00M¥ 13.78M
EBITDA
¥ -148.68M¥ -178.83M¥ -236.16M¥ -324.33M¥ -333.99M
Operating Income
¥ -198.78M¥ -230.55M¥ -280.24B¥ -333.35M¥ -419.83M
Other Income/Expenses
¥ 12.36M¥ -104.93M¥ -47.16M¥ -9.75M¥ -91.88M
Pretax Income
¥ -186.42M¥ -335.48M¥ -321.10M¥ -354.62M¥ -439.13M
Net Income
¥ -186.91M¥ -334.82M¥ -352.83M¥ -375.49M¥ -458.34M
Per Share Metrics
Basic EPS
¥ -0.36¥ -0.65¥ -0.62¥ -0.69¥ -0.99
Diluted EPS
¥ -0.36¥ -0.65¥ -0.62¥ -0.69¥ -0.99
Weighted Average Shares Outstanding
514.58M 514.58M 514.58M 514.58M 443.81M
Weighted Average Shares Outstanding (Diluted)
514.58M 514.58M 514.58M 514.58M 443.81M
Currency in CNY

Immunotech Biopharm Ltd Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis